SEOUL, March 2 South Korea fined Swiss drugmaker
Novartis 200 million won ($174,936.80) for paying
kickbacks to doctors in exchange for recommending the company's
drugs, its drug ministry said on Thursday.
The Ministry of Food and Drug Safety levied a fine on 30
drug items including Galvus and banned sales of 12 drugs
including Exelon for three months, a spokeswoman said.
The sales ban will be effective from March 17 through June
16, the ministry website showed.
Novartis Korea declined to comment.
In August last year, Novartis employees in South Korea were
indicted over illegal practices to boost sales of the company's
($1 = 1,143.2700 won)
(Reporting by Jane Chung; Editing by Stephen Coates)